• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

EyePod: Week in Review - September 3, 2023

News
Podcast

Orbis marks two decades of Cybersight telemedicine platform, unveils new app

Welcome to a special edition of the Ophthalmology Times EyePod podcast, providing all of the latest cutting-edge advancements.

Orbis International is marking the 20th anniversary of Cybersight, its telemedicine and e-learning platform.

The company noted in a news release Cybersight now has more than 85,000 registered eye care professionals hailing from nearly every country and region in the world. A new Cybersight mobile app is giving access to even more eye care professionals with its offline functionality, critical for eye teams working in areas with poor or no internet connection.

Through Cybersight, the company noted that medical professionals around the world can access training and education tools, courses and lectures anywhere, anytime – from a laptop, tablet or mobile phone. Cybersight's advanced features, including long-distance mentoring and an artificial intelligence (AI) diagnostic tool, are available for free for eye care professionals in low- and-middle-income countries, home to nine out of 10 people with vision loss.

According to the company, via Cybersight, Orbis's team of 400 world-leading Volunteer Faculty (medical experts) can deliver training and consultations without having to leave their homes. To date, the company noted Cybersight has delivered more than 30,000 consultations to help eye care professionals diagnose and treat patients with complex cases from all corners of the world, even reaching conflict-affected areas like Ukraine and Syria.

Orbis added that the Cybersight team has tackled detailed research to determine how eye care professionals benefit from the platform. The company noted the survey showed that professionals at all levels value Cybersight and of Cybersight users surveyed, the company indicated that 99% said the platform increased their knowledge and skills, 75% said it enabled them to make better informed decisions and 72% said Cybersight increased their professional confidence.

Orbis announced it recently rolled out a new Cybersight mobile app that provides even easier access to these services for eye care professionals. The company noted its app enables eye teams to create and respond to patient cases while offline, and automatically syncs when the user next connects to the internet.

Over the past two decades, Cybersight has proven to be critical for ophthalmic training, especially in recent years. As the COVID pandemic unfolded, Orbis was already set up to meet the needs of eye care professionals throughout the world – virtually. In the past four years, there have been more than 11 million views of Cybersight videos, over 119,000 webinar attendances and over 246,000 course enrollments.

Actress Debbie Allen joins Prevent Blindness, Regeneron to kick off the Gr8 Eye Movement to raise awareness of serious retinal diseases

Award-winning actress, dancer and director Debbie Allen is teaming up with Prevent Blindness and Regeneron to kick off the Gr8 Eye Movement, a new disease awareness campaign that aims to address gaps in how people understand the risk of developing certain serious retinal diseases, such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy.

According to a news release, the campaign will drive a moment in time to prioritize eye health regularly by designating the 8th of every month as a day to check in on vision. The organization noted the number “8” on its side looks like eyes and serves as a visual reminder for those who join the movement.

Allen said in the news release that maintaining vision has become a growing priority in her life.

Bruder Healthcare names Steven Fusco national account director

Bruder Healthcare announced today of Steven Fusco to its team as the national account director.

In the new role, Fusco will develop initiatives, foster partnerships, and accelerate growth opportunities to expand the company's reach and impact within the eye care sector.

According to a news release, Fusco has experience building revenue growth and commercial success in the eyecare industry.

Thank you for joining for another edition of the EyePod Week in Review podcast. Check out Ophthalmology Times.com for these and other articles that will help keep you ahead of the competition.

Related Videos
Video 6 - "Impact Of Durable Agents on Treatment Burden and Quality of Life in Retinal Diseases"
Video 5 - "Evolving Role of Steroids and Laser In DME"
Video 4 - "A Case of a DME Patient Achieving Extended Treatment Interval with New Therapy"
Video 3 - "Treating a DME Patient Lost to Follow-Up with a Highly Durable Agent"
Video 2 - "A Case of Neovascular AMD with Persistent Subretinal Fluid"
Video 1 - "A Case of Neovascular AMD With Treatment-Resistant Pigment Epithelium Detachment"
Video 1 - "Challenging the Definition of Dry Eye- Interpreting Diagnostic Tests"
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
© 2024 MJH Life Sciences

All rights reserved.